Revolution appoints J&J's Elizabeth McKee Anderson to board
This article was originally published in Scrip
Executive Summary
Revolution Medicines, a company developing innovative drugs by redesigning natural compounds, has named Elizabeth McKee Anderson, former worldwide vice-president of infectious diseases and vaccines at Janssen Pharmaceuticals, to its board of directors. Previously Ms Anderson has held several leadership positions within Johnson & Johnson, including vice-president of global biologics strategic marketing at Centocor, an operating company of Johnson & Johnson.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.